ArriVent BioPharma, Inc. AVBP Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from ArriVent BioPharma, Inc.’s reported figures.
Based on the most recent quarter.
The official record: ArriVent BioPharma, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about ArriVent BioPharma, Inc.'s quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ArriVent BioPharma, Inc.'s quick ratio?
- ArriVent BioPharma, Inc. (AVBP) reported quick ratio of 14× in Q1 2026.
- How has ArriVent BioPharma, Inc.'s quick ratio changed year-over-year?
- ArriVent BioPharma, Inc.'s quick ratio decreased by 2.7% year-over-year, from 14.3× to 14×.
- What is the long-term trend for ArriVent BioPharma, Inc.'s quick ratio?
- Over 2 years (2023 to 2025), ArriVent BioPharma, Inc.'s quick ratio has grown at a -3.4% compound annual growth rate (CAGR), from 13.8× to 12.8×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.